pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Apr 30·1 min read
save

Cigna to Leave ACA Individual Market in 2027, Shifting Focus to Core Business

Apr 30, 2026·read at STAT ↗RegulatoryNegative

Cigna announced it will withdraw from the Affordable Care Act’s individual exchanges starting in 2027, a move revealed on its first‑quarter earnings call.

The insurer currently covers about 369,000 members in ACA plans across 11 states, a modest portion of its 18.3 million total enrollees. Executives said the market offers limited growth potential.

By exiting, Cigna plans to redirect resources toward its Evernorth specialty‑care unit, pharmacy‑benefits business, and its flagship employer‑plan segment. The decision follows a $1.7 billion profit and an upgraded earnings outlook.

The pullout adds to recent turbulence in the ACA marketplace, where enrollment has slipped after Congress failed to extend extra subsidies.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “STAT+: Cigna will exit ACA individual markets next year, adding to tumult for patients”

read at STAT ↗
470 words · retrieved Apr 30
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
Protara Therapeutics, Inc.7
topics
Psychiatry & CNS

related stories

  • Sep 23The latest in the legal saga for youth gender-affirming care in the U.S.STAT
  • Sep 4Disabled workers at greater risk of losing health insuranceSTAT
  • Sep 4STAT+: Lindsay Clancy case exposes dangers of fragmented U.S. health system, experts saySTAT
  • Aug 17Everything the Trump administration did on health care last weekSTAT
  • Jul 15What to know about the parasitic diarrhea outbreakSTAT